Project HERCULES is a collaborative global project set up by Duchenne UK to increase the chances of patients with Duchenne muscular dystrophy (DMD) of accessing innovative treatments. It brings together pharmaceutical companies to develop a better evidence base to help support their case for the pricing and reimbursement of new treatments for DMD. 

To find out more about Project HERCULES and for the latest updates on the project, visit the Project HERCULES website.